Prior research on equity analysts focuses almost exclusively on those employed by sellside investment banks and brokerage houses. Yet investment firms undertake their own buy-side research and their analysts face different stock selection and recommendation incentives than their sell-side peers. We examine the selection and performance of stocks recommended by analysts at a large investment firm relative to those of sell-side analysts from mid-1997 to 2004. We find that the buy-side firm's analysts issue less optimistic recommendations for stocks with larger market capitalizations and lower return volatility than their sell-side peers, consistent with their facing fewer conflicts of interest and having a preference for liquid stocks. Tests with no controls for these effects indicate that annualized buy-side Strong Buy/Buy recommendations underperform those for sell-side peers by 5.9% using market-adjusted returns and by 3.8% using four-factor model abnormal returns. However, these findings are driven by differences in the stocks recommended and their market capitalization. After controlling for these selection effects, we find no difference in the performance of the buy-and sell-side analysts' Strong Buy/Buy recommendations.
INTRODUCTION
During the last twenty years, there has been considerable research on the performance of sell-side analysts who work for brokerage firms, investment banks and independent research firms (Elgers, Lo, and Murray, 1995 , Hilary and Menzly, 2006 , Kesavan, Gaur, and Raman, 2010 .
1 But because of data limitations, there has been very little research on buy-side analysts-that is analysts working for institutional investors such as mutual funds, pension funds, and hedge funds. Yet buy-side analysts are worthy of study in their own right. In 2006, U.S. and U.K. investment firms spent $7.7 billion on buy-side research versus $7.1 billion on sell-side research (see Tabb Group , 2006) .
Further, as we discuss below, there are important differences between buy-and sell-side analysts that are likely to affect their behavior and performance.
The limited research that is available on buy-side analysts employs a variety of research designs to examine their value and reports mixed findings. Cheng, Liu, and Qian (2006) find that portfolio managers rate research from the buy-side as almost three times more important to their decision-making than that of the sell-side. Frey and Herbst (2012) study buy-side analyst recommendations at a large global asset manager and find that changes in buy-side stock recommendations are followed by increases in the fund's trading in those stocks. Groysberg, Healy and Chapman (2008) show that earnings forecasts issued by buy-side analysts at a large investment firm are more biased and less accurate than those for sell-side peers covering the same firms. Busse, Green and Jegadeesh (2012) find that sell-side analysts' stock upgrades and downgrades have larger returns than buy and sell decisions of mutual fund portfolio managers for up to three months.
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Resolving whether buy-side research creates value is important for scholars interested in understanding how institutional factors and incentives affect research quality and value, but it is also highly relevant to managers at buy-side firms who face the 1 See Schipper (1991) and Bradshaw (2011) for reviews of the findings of this research. 2 Busse, Green and Jegadeesh (2012) examine a similar question to ours. However, they study the performance of portfolio managers rather than buy-side analysts. They also limit the return holding period to three months or shorter, whereas we examine performance over the full investment cycle, from when a stock is recommended as a buy to when it is downgraded. Finally, they compare portfolio manager buy/sell decisions to sell-side analysts' decisions to upgrade or downgrade a stock, whereas we compare buy recommendations for sell-side and buy-side analysts.
challenge of allocating limited research resources. In discussing this issue, the director of equity research at a mid-sized money management firm observed:
[Given] our falling budget … one option is to allow the budget cuts to fall primarily on sell-side research. In this course of action, we limit our access to sell-side experts and company management. We receive fewer company forecasts and less industry specific information. Given that we only have 6
analysts each covering about 80 stocks, we really need the sell-side to give us granular information about companies. By cutting sell-side research, we receive less qualitative/forward looking information. … However, so far this is the option I have gone with.
We revisit the question of the value of buy-side research by examining returns to recommendations issued by buy-side analysts at a large investment firm during the period 1997 to 2004. Their performance is benchmarked by recommendation returns for analysts at 85 sell-side firms with recommendations available throughout the sample period. Our research is well suited to test the value of buy-side research. Fifty percent of the bonus awards for buy-side analysts at our sample firm are based on the performance of their Strong Buy and Buy recommendations, the metric we analyze. In contrast, the buy-side analysts receive no direct reward for issuing accurate earnings forecasts, potentially explaining the earlier finding of their forecast inaccuracy. Recommendation performance also appears to have had little direct relation to sell-side analysts' bonus awards or job mobility (see Maber, 2011, and Mikhail, Walther and Willis, 1999) .
The importance of buy-side analyst recommendation performance for portfolio managers is underscored by several advantages of buy-side recommendations over those from the sell-side. The private information in buy-side recommendations is likely to facilitate profitable trading by the firm's portfolio managers, whereas sell-side recommendations are publicly disclosed to many institutions, generating an immediate stock price reaction (see Stickel, 1995 and Womack, 1996) and reducing some of the investment value of the recommendation. In addition, buy-side analysts are not subject to sell-side conflicts of interest from investment banking and brokerage businesses, and from concerns about preserving access to corporate managers. Evidence from prior studies suggests that these conflicts of interest reduce the performance of sell-side analysts' stock recommendations. 3 Despite these advantages, buy-side recommendations also have potential limitations. Interviews with managers at buy-and sell-side firms indicate that buy-side analysts typically cover more stocks than sell-side analysts, presumably reducing the depth and value of their analysis on any given stock. During the sample period, the buyside firm employs 46 analysts who on average each recommend 17 stocks. In contrast, the average sell-side firm employs 86 analysts who each issue recommendations for 12
stocks. In addition, prior research suggests that investment firms tend to invest in stocks with low return volatility (Sirri and Tufano, 1998) and high liquidity (see Falkenstein, 1996, Chen, Hong, Huang, and Kubik 2004) . By limiting their attention to these types of stocks, buy-side analysts may lower their recommendation returns. Returns generated by the buy-and sell-side analysts' stock recommendations depend critically on controls for differences in the types of firms covered. Marketadjusted and four-factor model abnormal returns from investing in Strong Buy/Buy recommendations are consistently lower for the buy-side firm than for sell-side firms.
The annual market-adjusted returns from investing in the buy-side firm's buy recommendations are 2.3% versus 8.2% for the average sell-side firm. This difference is partially explained by risk factors such as firm size, growth, momentum, and market risk.
3 Michaely and Womack (1999) and Barber, Lehavy and Trueman (2007) find that analysts with investment banking conflicts have less profitable recommendations than those with no such conflicts. Ertimur, Sunder and Sunder (2007) show that the translation of more accurate earnings forecasts into profitable recommendation returns holds only for non-conflicted analysts. In contrast, McNichols, O'Brien and Pamukcu (2006) find no evidence of lower returns for recommendations for sell-side analysts with conflicts of interest.
The average sell-side firm's recommendations are tilted towards smaller firms, whereas stocks recommended by the buy-side firm are size neutral. However, even after controlling for these factors, abnormal returns are 2.3% for the buy-side firm and 6.1%
for the average sell-side firm. This under-performance holds for seven of the eight sample years.
However, the under-performance of the buy-side firm's analysts appears to be largely attributable to differences in the stocks they select. After controlling for differences in the market capitalization of companies covered by analysts at the buy-side firm and their peers, the out-performance of sell-side Strong Buy/Buy recommendations disappears. The impact of stock selection on recommendation performance is reinforced by market-adjusted and abnormal returns for Strong Buy/Buy recommendations issued exclusively by sell-side analysts. The returns for these stocks are sizeable, particularly those for small cap stocks, which are likely to demand additional capital and therefore attract sell-side coverage. In contrast, Strong Buy/Buy recommendation returns for companies covered by both buy-and sell-side analysts are modest and comparable.
Additional tests examine several other potential explanations for the findings.
First, by comparing the performance of 27 analysts that the buy-side firm hires from the sell-side, we can control for differences in analyst skill. We find no evidence that buyside analysts have different skills than their sell-side peers. Second, to address concerns that our study uses data for only one buy-side firm, limiting the generality of our findings, we use a survey to collect additional recommendations from a broader sample of sell-side and buy-side analysts. The results confirm those reported for the sample firm.
Controlling for company selection, there is no significant difference in Strong Buy/Buy recommendation returns for buy-and sell-side analysts responding to the survey.
SAMPLE, DATA, AND TESTS

Sample and Data
Our buy-side recommendations are for analysts at a large money management firm for whom fundamental research is an important part of the stock selection process.
During the sample period, July 1997 to December 2004, bonus awards for analysts at the firm are based on two factors: market-adjusted returns generated from their Strong Buy and Buy recommendations (with a 50% weighting) and ratings from the firm's portfolio managers (comprising the remaining 50% weighting). In addition, the firm's top-rated analysts have long-term career opportunities within the research department and typically do not move into portfolio management.
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The buy-side firm is consistently ranked as one of the ten leading firms in
Reuters and Institutional Investor annual ratings of US fund management groups.
Morningstar ratings of the firm's equity fund performance (without regard to fund style) rank it above average versus the funds of other top ten firms for one-, three-, and fiveyear horizons. The mean annual market-adjusted return for the firm's large-cap equity funds (which are the most intensive users of its analyst reports) during the sample period exceeds 2.5%. Given these findings, the sample firm appears to be a strong performer. We collect similar recommendation data for sell-side analysts from Thomson's IBES. Since the buy-side firm survives throughout the sample period, our tests of buyside performance are subject to survivorship bias. In an attempt to control for any such bias, we require each sell-side firm to issue a minimum of five recommendations per 4 To assess whether our sample firm is comparable to other large money management firms, we also interview buy-side analysts and research directors at competitor firms. Their descriptions of their research businesses, as well as the ways they reviewed and rewarded buy-side analysts are very similar to that reported for our sample firm, increasing our confidence that it is not an outlier. 5 Malkiel (1995) reports that equity mutual funds underperform the S&P 500 on average by 1.83% from 1982 to 1991. Wermers (2000) finds that equity mutual funds outperform the S&P 500 by 1.5% from 1975 to 1994. Both estimates are lower than the average market adjusted performance of the funds of the buy side firm in our sample.
calendar year throughout the sample period, implying that the sell-side sample also 
Stock Selection Tests
Prior research suggests that there are likely to be important differences in the number and type of stocks selected for coverage by buy-and sell-side analysts that could affect recommendation performance. We examine several such factors:
1. Firm Scale and Scope of Coverage. As discussed above, given differences in research scale, buy-side firms typically employ fewer analysts than sell-side firms and expect their analysts to cover many more stocks. Clement (1999) argues that analysts who cover a larger number of firms face greater task complexity and are able to devote less time to any particular stock, affecting the quality of their recommendations. Clement also argues that firms that employ more analysts are able to take advantage of economies of scale and provide their analysts with more resources. To examine these factors, we compute the average number of stocks recommended per analyst at each sample firm (NRECS) and the number of analysts employed by the firm (NANL) over the sample period.
2. Return Volatility of Recommended Stocks. Sirri and Tufano (1998) find that fund flows and, therefore, the asset base upon which buy-side firms charge management fees, decrease as the volatility of fund returns increases. As a result, portfolio managers are likely to encourage their buy-side analysts to cover and recommend stocks with relatively low daily portfolio return volatility. Since portfolio managers' are typically evaluated for out-performing size and risk benchmark portfolios, they are expected to be particularly averse to stocks with high abnormal volatility since risks for these stocks are less likely to be reflected in benchmark performance. To examine whether there are differences in the volatility of stocks recommended by the buy-and sell-side analysts we therefore compute the standard deviation of four-factor model daily abnormal returns for buy recommendations at each sample firm during the sample period (SVOL). Recommended. Falkenstein (1996) 
Liquidity of Stocks
Conflicts of Interest.
Prior research indicates that sell-side analysts face conflicts of interest arising from investment banking or brokerage businesses. Analysts working for investment banks are expected to cover stocks of banking clients and face pressure to issue positive recommendations for such firms (see Lin and McNichols, 1998 , Michaely and Womack, 1999 , Dechow, Hutton and Sloan, 2000 , and Lin, McNichols and O'Brien, 2005 . 7 In addition, sell-side analysts issue optimistic recommendations to encourage clients to purchase stocks and generate brokerage commissions (see Cowen, Groysberg and Healy, 2006) . Analysts at the sample buy-side firm face no such pressures. The potential impact of these banking and brokerage incentives on analysts' stock recommendation performance, however, is unclear. If they resulted in sell-side analysts issuing upwardly biased recommendations, the sell-side was likely to underperform the given the small number of such recommendations.
Return Tests
Our tests of the stock performance of the buy-side firm's recommendations focus primarily on its analysts' Strong Buy and Buy recommendations. 8 Given their use in buyside analyst compensation, these recommendations are expected to be most important for both the firm and its analysts and therefore provide a powerful test of the value of their research. 9 To construct our returns, a stock rated as a Strong Buy or Buy is bought and held from the trading day after its initial Strong Buy/Buy recommendation until the trading day after it is downgraded to a Hold, Underperform or Sell (if it continues to be covered) or, if coverage is discontinued, for 250 trading days (the typical horizon of analysts' recommendations). We delay purchasing or selling a stock until the trading day after a recommendation changed to ensure that investors have access to the new recommendation and can modify their portfolios. The results therefore exclude any announcement day returns for recommendation changes, which likely leads us to understate the returns to sell-side recommendations given prior evidence that changes in their recommendations had an immediate effect on stock prices (see Stickel, 1995 and Womack, 1996) . However, we believe that this delay in executing a trade is necessary to allow portfolio managers to have sufficient time to adopt the buy-side recommendations.
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Returns are estimated for portfolios of Strong Buy/Buy stocks for each buy-side and sell-side firm. Our analysis uses returns for firms rather than analysts because we are concerned about potential dependencies in recommendation behavior and returns for analysts at the same firm. This could arise if macro research at a given firm takes a particular position on market prospects that affects recommendations and returns for all analysts at the firm. Firm portfolio returns control for such dependencies.
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We compute the daily return for each sample buy-and sell-side firm (R jt ) as follows:
where R it is the daily return on a stock, x ijt takes the value one if the stock is recommended as a Strong Buy or Buy on day t-1 by an analyst at firm j, and n t is the number of recommended stocks on day t. We update the portfolio for each firm daily to add newly upgraded stocks and delete stocks that are downgraded or dropped. This generates a time series of daily buy recommendation returns for each buy/sell-side firm.
To control for market and risk effects that drive stock returns, we compute daily market-adjusted returns, the metric used by the buy-side firm to evaluate analyst performance, and abnormal returns for each firm. Daily market-adjusted returns are the difference between the buy recommendation return for each firm less the return on the value-weighted S&P 500 market index. We annualize the sample period average daily market-adjusted return for each firm, assuming a 250-trading day year.
The second return metric, abnormal returns, controls for risk and other factors known to be associated with stock performance using the four-factor model developed by Carhart (1997) :
10 Including the announcement day returns increases the returns to sell-side Strong Buy/Buy recommendations, but it does not change the inferences in the paper. 11 Our approach is similar to Barber, Lehavy and Trueman (2007) , who compare the stock recommendation performance of investment banks and independent research firms. To assess whether our results are sensitive to using firm returns rather than analyst returns, we re-estimate our tests using the Barber, Lehavy, McNichols and Trueman (2003) To compare the performance of buy-and sell-side firms, we estimate the following model:
R ma,j and  j are the average annual market-adjusted and annualized average abnormal buy recommendation returns for firm j, and BUYSIDE j is an indicator variable that takes the value one for the buy-side firm and zero otherwise. The coefficient () on this variable indicates whether the market-adjusted or abnormal return for the buy-side firm is different from those for sell-side firms. The t-statistic on this estimate is used to infer whether there is a statistically significant difference in returns for the buy-side firms relative to its sell-side peers. There is also evidence that buy-side analysts recommend less volatile and larger market capitalization stocks than their sell-side peers. The average daily standard deviation of abnormal returns for buy-rated stocks is 0.42% for the buy-side and 0.95%
RESULTS
Stock Selection
for the average sell-side firm. This difference is highly statistically reliable and implies that the stocks recommended by buy-side analysts have lower daily return volatility, consistent with portfolio managers encouraging buy-side analysts to cover and recommend low volatility stocks to facilitate managing funds flow and management fees (see Sirri and Tufano, 1998) . In addition, stocks recommended by the buy-side firm analysts have an average market capitalization that is almost seven times larger than the average sell-side recommendation ($9.1 billion versus $1.3 billion). This difference is both economically and statistically significant. We find no significant difference in daily turnover for buy-and sell-side recommendations. To explore whether the Global Research Settlement affected the relative optimism of sell-side analysts' recommendations, we also estimate changes in sell-and buy-side analysts' average ratings around the regulatory change. We find that both sell-side and the buy-side firms become less optimistic after the Global Settlement. We find no evidence of any incremental change for sell-side firms, but interpret these findings with caution given the turbulent market conditions at the time. Four-factor abnormal returns are also reported in table 4 along with estimated factor loadings. The loading on the size factor for the buy-side firm is 0.12 compared to an average loading of 0.64 for the sell-side firms, implying that sell-side firms'
Strong Buy/Buy Recommendation Performance
recommendations are tilted towards small firms whereas the buy-side firm recommendations are almost size neutral. Other loading differences are insignificant.
After controlling for these factor differences, we find that the relative outperformance of sell-side recommendations declines but continues to be economically and statistically significant. The annualized abnormal return for the buy-side firm is 2.3%, and statistically insignificant. In contrast, the average sell-side firm annualized abnormal return is 6.1%, significantly different from zero and significantly greater than that for the buy-side firm. 13 The median sell-side firm's abnormal return is 5.3%, also significantly higher than the buy-side firm's return. The buy-side firm's Strong Buy/Buy recommendation abnormal return ranks at the 76 th percentile relative to sell-side firms.
For completeness, (2007)). However, the returns reported in our study should be interpreted with caution due to the survival bias for both the buy-and sell-side firms.
For Strong Buys, annual market-adjusted returns are 3.6% for analysts at the buy-side firm and 8.9% for their sell-side peers. Abnormal returns that adjust for four-factor risks are 3.4% for the buy-side firm's analysts and 6.4% for their sell-side peers. For Buy recommendations, mean market-adjusted returns are 1.1% and insignificant for the buyside and 6.6% (statistically reliable) for sell-side analysts. Abnormal returns are 1.0% for the buy side (insignificant) and 4.9% (significant) for the sell-side.
The sample period covers a wide range of market conditions, including the bull technology market of the late 1990s and the crash in technology stocks in 2000 and 2001.
To examine the sensitivity of our findings to differing market conditions, we replicate our tests for each sample year. The findings, reported in In summary, during the sample period, Strong Buy/Buy recommendations for the average sell-side firm generate higher returns than those for the buy-side firm. This difference is both statistically and economically significant. Results of annual performance differences indicate that the sell-side returns beat those of the buy-side firm in six or seven of the eight sample years.
14 The Wilcoxon Signed Ranks Test uses information about both the magnitude and sign of differences to infer statistical significance.
Hold and Sell Recommendation Performance
We also report findings for For Underperform/Sell recommendations, the average market-adjusted and abnormal returns for buy-side analysts' Underperform/Sell recommendations are -1.3%
and -1.1% respectively, both statistically insignificant and no different from those for the average sell-side firm.
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Stock Selection and Buy Recommendation Performance
To understand whether differences in factors predicted to affect stock selection are related to the superior buy recommendation returns for sell-side analysts, we estimate the following regression model:
15 The superior performance of Hold returns over those for Strong Buy/Buy recommendations for buy-side analysts is inconsistent with the pattern for sell-side analysts reported in this study and in prior research (see for example, Barber, Lehavy, McNichols and Trueman, 2001, p. 534) . 16 These findings exclude two influential observations for financially distressed companies with stock prices less than $1 that showed large percentage (but modest monetary) gains in value during the recommendation period. If these observations are included, the annualized market-adjusted and abnormal returns from buy-side Underperform/Sell ratings are 13.0% and 9.5% respectively, significantly greater than the -2.5% and -1.1% for the average sell-side firm.
 is the average four-factor model abnormal return to Strong Buy/Buy recommendations issued by analysts at a given firm. BUYSIDE is an indicator variable that takes the value one for the buy-side firm and zero otherwise. REC is an indicator variable that takes the value 1 for strong buy recommendations, 2 for buys, 3 for holds, etc., and is constructed to control for differences in recommendation optimism. The remaining variables are defined above. The model is estimated using time-series averages of the dependent and independent variables for each firm to allow for dependencies in the variables within firms. Since is an estimate from a first-stage regression, we adjust the standard errors in the second stage model by taking account of measurement error and the loss of degrees of freedom using the approach proposed by Murphy and Topel (1985) .
The regression results are reported in Mean abnormal returns for these two portfolios are 11.7% and 4.7% respectively. A difference in means test indicates that the small versus large company differences are statistically as well as economically significant for both metrics.
In summary, much of the under-performance of buy-side analysts' Strong Buy/Buy recommendations comes from differences in stock selection. Both buy-and sellside analysts cover large stocks that presumably offer the liquidity demanded by the firm's portfolio managers. But sell-side analysts also recommend smaller stocks, perhaps because these companies are active in raising new capital and are therefore actual or potential investment banking clients. The high returns from these recommendations boost sell-side analysts' recommendation returns and fully explain their superior performance.
Additional Tests
( poor performing recommendations, a potential cause for concern in interpreting our findings.
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To examine whether this potential bias explains the strong performance of sellside analysts in our tests, we re-estimate sell-side Buy recommendation returns using data from Reuters. To the best of our knowledge, Reuters database is not updated by analysts and is therefore less likely to be subject to bias introduced by analyst "corrections." The Reuters sample is 56 sell-side firms that satisfy the data requirements discussed in section 2. These firms are somewhat larger than the IBES sample firm. On average each firm in the Reuters sample employs 94 analysts, and issues 3,837 recommendations per year for 833 different stocks. In contrast, the average IBES sample firm employs 86 analysts and issues 2,064 recommendations per year for 671 different stocks. Nonetheless, results using the Reuters database are very similar in magnitude and statistical reliability to those reported above for the IBES sample. The average (median) market-adjusted return for sell-side firms is 8.1% (7.4%) and the average (median) abnormal return is 6.2% (6.1%).
(2) Differences in Buy-and Sell-Side Analyst Skill. Another competing explanation for our findings is that sell-side firms draw their analysts from a more talented labor pool than did buy-side firms. Although this hypothesis does not explain why we find the outperformance of sell side analysts to have been driven by their recommendations for 17 Since the Ljungqvist et. al. study, IBES has investigated its recommendation data and updated its database to correct for any observed errors. We use the updated IBES data for our primary tests.
small stocks. To make sure that our results are robust when we hold analyst skill constant, we compare the performance of buy-side analysts who switch to or from the sell-side during the sample period. Twenty-seven of the sample firm's analysts work at sell-side firms at some point during the sample period. We compare the average performance of the stock recommendations for these analysts during their buy-and sellside employment. Since the analyst is held constant in the test, we effectively control for any differences in analyst ability. Results are reported in Table 9 .
The Strong Buy/Buy recommendations for these switching analysts generate mean market-adjusted returns of 4.7% during their sell-side employment, and -2.0% during their buy-side years. Comparable four-factor abnormal returns are 1.7% and -0.3%
respectively. Neither of the differences in market-adjusted or abnormal returns across the two employment periods is statistically significant. When we impose the additional restriction that each portfolio includes only stocks that the analyst recommends both before and after the switch to the buy-or sell-side, we find that the market-adjusted and abnormal return differences are even smaller. Specifically, the Strong Buy/Buy recommendations for these switching analysts generate market-adjusted returns of 1.9%
during their sell-side employment, and -1.8% during their buy-side years. Four-factor abnormal returns are 0.7% and -0.3% during the sell-side and buy-side years respectively.
(3) Generalizability. One limitation of our study is that our sample of buy-side analysts is from a single firm, raising questions about whether the findings can be generalized to other investment firms. Ideally, our tests would have used recommendation data from analysts at multiple investment firms. But we do not have access to such data. However, we are able to obtain recommendations for buy-and sell-side analysts from two surveys we conducted in 2005 and 2006. The surveys request more than 5,000 analysts to provide us anonymously with recommendations for three stocks that they cover from a list of S&P 500 companies in the industries they indicated they covered. We receive responses from There are several important differences between the survey recommendations and those analyzed in the earlier tests. First, we observe the date that we receive a given analyst's survey recommendations, but not the date that those recommendations are originally issued. Second, we do not have information on whether or when the survey analysts subsequently revise their recommendations. As a result, we are obliged to modify the trading strategy to estimate recommendation performance. For the Strong Buy/Buy strategy we purchase stocks recommended as Strong Buys/Buys on the date we receive the survey response and hold them for the next 250 trading days, the investment horizon of analyst recommendations.
Given our limit on the companies covered by the survey, recommendations made by both the buy-and sell-side samples are for large companies. The mean market cap of stocks recommended by buy-side analysts is $30.7 billion versus $27.6 billion for those recommended by the sell-side. The difference is insignificant, increasing our confidence that the recommended stocks for the two subsamples have similar size/liquidity and that the selection differences documented above are unlikely to be important for the survey findings.
The average market-adjusted Strong Buy/Buy recommendation return for the survey buy-side analysts is 1.4% versus 2.3% for the sell-side analysts. Mean four factor abnormal returns are 3.2% for buy-side analysts and 3.0% for sell-side peers. None of these means is individually significant, and the differences between the buy-and sell-side samples are also insignificant.
In summary, the survey findings are consistent with those reported for the buyside firm and the size-adjusted sell-side sample, and indicate that after controlling for stock selection, there is no significant difference in the performance of buy-and sell-side analysts Strong Buy/Buy recommendations. However, we interpret these findings with caution, as the surveys are subject to potential response bias and other limitations.
CONCLUSIONS
We examine buy recommendation performance for analysts at a large, buy-side firm relative to analysts at sell-side firms covered by IBES throughout the sample period (mid-1997 to 2004) . We find that buy-side firm analysts recommend stocks with stock return volatility roughly half that of average sell-side analysts' recommended stocks (0.42% versus 0.95%), and market capitalizations almost seven times larger ($9.1 billion versus $1.3 billion). We interpret these findings as indicating that portfolio managers (buy-side analysts' clients) prefer that buy-side analysts cover less volatile and more liquid stocks. Sell-side analysts cover these same firms, but also cover smaller less liquid firms, perhaps because they are actual or potential investment banking clients.
In addition, we find that the buy-side firm analysts' stock recommendations are less optimistic than their sell-side counterparts', consistent with buy-side analysts facing fewer conflicts of interest. Forty-four percent of the recommendations issued by the buyside firm are Strong Buy or Buy ratings, versus 56% for analysts at sell-side firms. The higher frequency of sell-side Strong Buy/Buy recommendations is offset by a lower frequency of Underperform and Sell ratings (14% for the buy-side firm analysts versus 7% for analysts at sell-side firms).
Univariate tests of market-adjusted and abnormal returns from investing in Strong
Buy/Buy recommendations indicate that analysts at the buy-side firm consistently underperform their peers at the average sell-side firm. Annualized market-adjusted returns from investing in the buy-side firm's buy recommendations are 2.3%, compared to 8.2%
for sell-side firms. Abnormal buy recommendation returns for the buy-side firm are also 2.3%, versus a mean of 6.1% for sell-side firms. Relative to its sell-side peers, the buyside firm Buy recommendation returns rank in the lowest quartile. Finally, this pattern of underperformance for the buy-side firm holds for six or seven of the eight sample years.
However, these results change once we control for the market capitalizations of the firms recommended. Multivariate tests show a significant negative relation between Strong Buy/Buy recommendation abnormal returns, even those that incorporate the size factor, and the market capitalization of stocks recommended. After controlling for this effect, we find no difference in the performance of Strong Buy/Buy recommendations for the buy-side firm and its sell-side peers. Additional tests also show no difference in the Strong Buy/Buy recommendation returns of stocks covered by both buy-and sell-side analysts. In contrast, there are sizable abnormal returns for recommended stocks covered only by sell-side analysts, particularly those with small market capitalizations.
One plausible interpretation of these findings is that buy-side analysts deliberately cover large stocks because they are the types of liquid stocks their portfolio managers were willing to buy. Such a restriction limits the returns that can be earned from buy-side recommendations, as documented earlier by Chen, Hong, Huang, and Kubik (2004) . But it does not undermine buy-side analysts' credibility with large fund portfolio managers since they face similar constraints themselves. Not surprisingly, sell-side analysts cover the same large cap liquid stocks. But they also cover high-performing small cap stocks, perhaps because these stocks are past clients or are potential future clients.
The findings are robust to analysis using recommendations from Reuters rather than IBES, to controls for analyst skill (comparing analysts who switch to the buy-side from the sell-side), and to the use of recommendations for buy-and sell-side analysts from a 2005/6 survey.
Our finding that buy-side research fails to out-perform that of sell-side analysts raises questions about whether investment firms should continue to rely on their own research rather than using research from sell-side analysts. One explanation for their joint survival, given our findings, is that the two types of research reinforce and complement each. But we also recognize that our analysis is incomplete because we do not have information on the relative cost of the two forms of research.
Our study also raises several questions for scholars. Despite our best efforts to examine the generality of our findings, we are limited to recommendations for a single buy-side firm and to analysts from multiple buy-and sell-side firms that completed a survey. Future studies can extend the analysis by studying other buy-side firms. Do our findings hold more generally? Do they hold for smaller mutual funds whose managers and analysts are less constrained by liquidity? Do they hold for analysts at hedge funds that are able to short stocks? Answers to these questions might help sell-side and buy-side executives allocate their financial and human resources more strategically. Number of firms 1 85 **, * Significant at the 1% and 5% level respectively using a two-tailed test. ns Not significant at the 5% level or lower using a two-tailed test. a We construct buy recommendation portfolios for each sample firm by buying and holding stocks rated by the firm's analysts as a Strong Buy or Buy from the day after the initial recommendation is announced until the day after they were downgraded to a Hold or lower rating (if they continued to be covered), or for 250 days (if they ceased to be covered). Market-adjusted returns are returns to a firm's buy recommendation portfolio less the return on the value-weighted S&P 500 market index. Abnormal returns are computed for each firm's buy recommendation portfolio by regressing daily portfolio returns on the market excess return, a zero-investment size portfolio return, a zero investment book-to-market portfolio return and a zero investment price momentum portfolio return. The abnormal return is the annualized regression intercept based on a 250 trading day year. a We construct buy recommendation portfolios for each sample firm by buying and holding stocks rated by the firm's analysts as a Strong Buy or Buy from the day after the initial recommendation is announced until the day after they were downgraded to a Hold or lower rating (if they continued to be covered), or for 250 days (if they ceased to be covered). Market-adjusted returns are returns to a firm's buy recommendation portfolio less the return on the value-weighted S&P 500 market index. Abnormal returns are computed for each firm's buy recommendation portfolio by regressing daily portfolio returns on the market excess return, a zero-investment size portfolio return, a zero investment book-to-market portfolio return and a zero investment price momentum portfolio return. The abnormal return is the annualized regression intercept based on a 250 trading day year. b The p level is for a two-tailed Wilcoxon Signed Ranks Test Number of firms 1 11 * Significant at the 5% level using a two-tailed test. ns Not significant at the 5% level or lower using a twotailed test. a We construct buy recommendation portfolios for each sample firm by buying and holding stocks rated by the firm's analysts as a Hold or Underperform/Sell from the day after the initial recommendation is announced until the day after they were changed to another rating (if they continued to be covered), or for 250 days (if they ceased to be covered). Market-adjusted returns are returns to a firm's buy recommendation portfolio less the return on the value-weighted S&P 500 market index. Abnormal returns are computed for each firm's buy recommendation portfolio by regressing daily portfolio returns on the market excess return, a zero-investment size portfolio return, a zero investment book-to-market portfolio return and a zero investment price momentum portfolio return. The abnormal return is the annualized regression intercept based on a 250 trading day year. Adjusted R-squared 0.4% 4.7% 12.2% **, * Significant at the 1% and 5% level respectively using a two-tailed test. ns Not significant at the 5% level or lower using a two-tailed test.
a The dependent variable is the mean abnormal return to buy recommendations at a given firm throughout the sample period. To estimate the mean recommendation for a firm (REC), Strong Buy recommendations are assigned the value 1, Buys 2, Holds 3, etc.). The model is estimated using time-series averages of the dependent and independent variables for each firm to allow for dependencies in the variables within firms. Firms covered by both the buy-and sell-side 2.30% ns 2.30% ns **, * Significant at the 1% and 5% level respectively using a two-tailed test. ns Not significant at the 5% level or lower using a two-tailed test.
a We construct buy recommendation portfolios for each sample firm by buying and holding stocks rated by the firm's analysts as a Strong Buy or Buy from the day after the initial recommendation is announced until the day after they were downgraded to a Hold or lower rating (if they continued to be covered), or for 250 days (if they ceased to be covered). Market-adjusted returns are returns to a firm's buy recommendation portfolio less the return on the value-weighted S&P 500 market index. Abnormal returns are computed for each firm's buy recommendation portfolio by regressing daily portfolio returns on the market excess return, a zero-investment size portfolio return, a zero investment book-to-market portfolio return and a zero investment price momentum portfolio return. The abnormal return is the annualized regression intercept based on a 250 trading day year. Table 9 Results of robustness tests for analysts switching form sell-side firms to the buy side firm, and for recommendations from survey of buy-and sell-side analysts. 
